Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629Phase 2
Key facts
- Status
- Completed
- Start
- Sep 2001
- Countries
- 1
- Sponsor
- Duke University
- Modality
- Small Molecules
- Drugs
- zolpidem
- Conditions
- Insomnia
01
Overview
Phase 2, randomised, double-blind trial of zolpidem in Insomnia (3 arms), sponsored by Duke University. Started Sep 2001; status: completed.
02
Design
3 arms- Study design
- RandomizedDouble-blind
CBT + Ambien
Cognitive Behavioral Therapy plus zolpidem tartrate
CBT + Placebo
Cognitive Behavioral Therapy plus placebo
CBT alone
Cognitive Behavioral Therapy alone
03
Who it enrols
Adults aged 21-75 with chronic insomnia (>6 months) and poor sleep hygiene, excluding those with major psychiatric disorders, sleep apnea, or dependence on hypnotics.
Beyond the preview
Go deeper on NCT00044629.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044629.